These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23228658)

  • 1. Decreased plasma levels of soluble low density lipoprotein receptor-related protein-1 (sLRP) and the soluble form of the receptor for advanced glycation end products (sRAGE) in the clinical diagnosis of Alzheimer's disease.
    Liang F; Jia J; Wang S; Qin W; Liu G
    J Clin Neurosci; 2013 Mar; 20(3):357-61. PubMed ID: 23228658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of soluble receptor for advanced glycation end products in Alzheimer's disease.
    Xu XY; Deng CQ; Wang J; Deng XJ; Xiao Q; Li Y; He Q; Fan WH; Quan FY; Zhu YP; Cheng P; Chen GJ
    Int J Neurosci; 2017 May; 127(5):454-458. PubMed ID: 27323891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients.
    Hernanz A; De la Fuente M; Navarro M; Frank A
    Neuroimmunomodulation; 2007; 14(3-4):163-7. PubMed ID: 18073509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of plasma biomarkers and clinical data for the detection of sporadic Alzheimer's disease.
    Han Y; Jia J; Jia XF; Qin W; Wang S
    Neurosci Lett; 2012 May; 516(2):232-6. PubMed ID: 22503901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia.
    Emanuele E; D'Angelo A; Tomaino C; Binetti G; Ghidoni R; Politi P; Bernardi L; Maletta R; Bruni AC; Geroldi D
    Arch Neurol; 2005 Nov; 62(11):1734-6. PubMed ID: 16286548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
    Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
    Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of p53(ser15) and p21/p21(thr145) in peripheral blood lymphocytes as potential Alzheimer's disease biomarkers.
    Tan M; Wang S; Song J; Jia J
    Neurosci Lett; 2012 May; 516(2):226-31. PubMed ID: 22503900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-β is an early biomarker for mild cognitive impairment preceding Alzheimer's disease.
    Sagare AP; Deane R; Zetterberg H; Wallin A; Blennow K; Zlokovic BV
    J Alzheimers Dis; 2011; 24(1):25-34. PubMed ID: 21157031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased plasma sRAGE levels in COPD: influence of oxygen therapy.
    Gopal P; Rutten EP; Dentener MA; Wouters EF; Reynaert NL
    Eur J Clin Invest; 2012 Aug; 42(8):807-14. PubMed ID: 22288943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients.
    Jabaudon M; Futier E; Roszyk L; Chalus E; Guerin R; Petit A; Mrozek S; Perbet S; Cayot-Constantin S; Chartier C; Sapin V; Bazin JE; Constantin JM
    Crit Care Med; 2011 Mar; 39(3):480-8. PubMed ID: 21220996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
    Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
    Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease.
    Yamagishi S; Nakamura K; Inoue H; Kikuchi S; Takeuchi M
    Med Hypotheses; 2005; 64(6):1205-7. PubMed ID: 15823718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid markers in differential diagnosis of Alzheimer's disease and vascular dementia.
    Boban M; Grbić K; Mladinov M; Hof PR; Süssmair C; Ackl N; Stanić G; Bader B; Danek A; Simić G
    Coll Antropol; 2008 Jan; 32 Suppl 1():31-6. PubMed ID: 18405055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble receptor for advanced glycation end products in critically ill patients and its associations with other clinical markers and 28-day mortality.
    Cheng Y; Zhong J; Xiang Y; Zeng F; Cai D; Zhao L
    Clin Interv Aging; 2014; 9():1981-6. PubMed ID: 25429209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood Triglyceride and High-Density Lipoprotein Levels Are Associated with Plasma Amyloid-β Transport: A Population-Based Cross-Sectional Study.
    Wei S; Shang S; Dang L; Gao F; Gao Y; Gao L; Chen C; Huo K; Wang J; Wang J; Qu Q
    J Alzheimers Dis; 2021; 84(1):303-314. PubMed ID: 34542070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G1/S checkpoint proteins in peripheral blood lymphocytes are potentially diagnostic biomarkers for Alzheimer's disease.
    Song J; Wang S; Tan M; Jia J
    Neurosci Lett; 2012 Sep; 526(2):144-9. PubMed ID: 22922216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High plasma levels of the soluble receptor for advanced glycation endproducts in patients with symptomatic carotid atherosclerosis.
    Basta G; Castagnini M; Del Turco S; Epistolato MC; Righini P; Sangiorgi GM; De Caterina R; Tanganelli P
    Eur J Clin Invest; 2009 Dec; 39(12):1065-72. PubMed ID: 19811526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control.
    Pullerits R; Bokarewa M; Dahlberg L; Tarkowski A
    Arthritis Res Ther; 2005; 7(4):R817-24. PubMed ID: 15987483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the Pro12Ala polymorphism of PPAR-gamma on age at onset and sRAGE levels in Alzheimer's disease.
    Yao L; Li K; Zhang L; Yao S; Piao Z; Song L
    Brain Res; 2009 Sep; 1291():133-9. PubMed ID: 19631630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of soluble receptor for advanced glycation end-product with increasing central aortic stiffness in hypertensive patients.
    Yoon SJ; Park S; Park C; Chang W; Cho DK; Ko YG; Choi D; Kwon HM; Jang Y; Chung N
    Coron Artery Dis; 2012 Mar; 23(2):85-90. PubMed ID: 22198512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.